Novosti
Khirurgii

 This journal is
indexed in Scopus
journal cover
android icon Android Applicaion

Year 2019 Vol. 27 No 5

REVIEWS

V.A. GOMBOLEVSKIY 1, A.E. NIKOLAEV 1, A.N. SHAPIEV 1, A.O. KOSOLAPOV 2, P.B. GELEZHE 1, 2, A.A. BARCHUK 3, P.A. DREVAL 4, Y.S. ESAKOV 5, S.P. MOROZOV 1

MANAGEMENT OF PATIENTS WITH SOLID PULMONARY NODULES DETECTED IN LUNG CANCER SCREENING

Research and Practical Clinical Center of Diagnostics and Telemedicine Technologies1,
European Medical Center 2,
N.N. Petrov National Medical Research Center of Oncology 3,
Moscow City Oncological Hospital ¹ 624,
A.V. Vishnevsky Institute of Surgery5 Moscow,
The Russian Federation

According to the low-dose computed tomography, conducted as a part of the screening, the pulmonary nodule is the most common finding, but the primary low-dose computed tomography does not allow determining the etiology, so these patients are repeated the low-dose computed tomography depending on the size, or additional methods of examination and verification are performed.
In the international medical communities that develop lung cancer screening programs, a fundamental place is occupied by guideline for pulmonary nodules identified by low-dose computed tomography.
The literature review is devoted to the relevance of the problem in pulmonary nodule verification with additional studies (computed tomography, positron emission tomography combined with computed tomography) and different variations of biopsies under visualization control (under the control of CT, ultrasound). It is shown that different methods of verification are to be used most efficiently depending on the localization of pulmonary nodule, as well as on the basis of the oncoconsilium decision.
Unfortunately, the analysis of the literature revealed no scientific papers showing the positive and negative sides of subpleural biopsy nodules identified in the screening under the control of ultrasound and computed tomography. When assessing pulmonary nodule using such an expensive method as positron emission tomography combined with computed tomography, which have many false positive results. In subpleural localization of the pulmonary nodule it is more rational to use biopsy under visualization control. Conducting in this aspect of large prospective randomized controlled studies would allow a more reasonable approach to the selection of the choice verification and additional methods for assessing pulmonary nodule.

Keywords: low-dose computed tomography, lung cancer screening, lung cancer, biopsy of subpleural nodules, nodule verification, guideline for pulmonary nodules, solid nodules
p. 553-562 of the original issue
References
  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394-24. doi: 10.3322/caac.21492
  2. National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011 Aug 4;365(5):395-409. doi: 10.1056/NEJMoa1102873
  3. Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, Byers T, Colditz GA, Gould MK, Jett JR, Sabichi AL, Smith-Bindman R, Wood DE, Qaseem A, Detterbeck FC. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012 Jun 13;307(22):2418-29. doi: 10.1001/jama.2012.5521
  4. Field JK, Smith RA, Aberle DR, Oudkerk M, Baldwin DR, Yankelevitz D, Pedersen JH, Swanson SJ, Travis WD, Wisbuba II, Noguchi M, Mulshine JL. International association for the study of lung cancer computed tomography screening workshop 2011 report. J Thorac Oncol. 2012 Jan;7(1):10-19. doi: 10.1097/JTO.0b013e31823c58ab
  5. Horeweg N, van der Aalst CM, Thunnissen E, Nackaerts K, Weenink C, Groen HJ, Lammers JW, Aerts JG, Scholten ET, van Rosmalen J, Mali W, Oudkerk M, de Koning HJ. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. Am J Respir Crit Care Med. 2013 Apr 15;187(8):848-54. doi: 10.1164/rccm.201209-1651OC
  6. Humphrey LL, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, Zakher B, Fu R, Slatore CG. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation. Ann Intern Med. 2013 Sep 17;159(6):411-20. doi: 10.7326/0003-4819-159-6-201309170-00690
  7. Petrova GV, Kaprin AD (red), Gretsova OP, Starinskii VV (red). Zlokachestvennye novoobrazovaniia v Rossii obzor statisticheskoi informatsii za 1993-2013 gg. [Internet]. Mosñow F; 2015. 511 p http://www.oncology.ru/service/statistics/malignant_tumors/1993-2013.pdf (in Russ.)
  8. Kaprin AD, Starinskii VV, Petrova GV (red). Zlokachestvennye novoobrazovaniia v Rossii v 2017 godu (zabolevaemost’ i smertnost’) [Internet]. Moscow, RF; 2018. 250 p. http://www.oncology.ru/service/statistics/malignant_tumors/2017.pdf (in Russ.)
  9. Kaprin AD, Starinskii VV, Petrova GV, red. Sostoianie onkologicheskoi pomoshchi naseleniiu Rossii v 2017 godu [Internet]. Moscow, RF; 2018. 236 p. http://www.oncology.ru/service/statistics/condition/2017.pdf (in Russ.)
  10. Wille MM, Dirksen A, Ashraf H, Saghir Z, Bach KS, Brodersen J, Clementsen PF, Hansen H, Larsen KR, Mortensen J, Rasmussen JF, Seersholm N, Skov BG, Thomsen LH, Tønnesen P, Pedersen JH. Results of the randomized danish lung cancer screening trial with focus on high-risk profiling. Am J Respir Crit Care Med. 2016 Mar 1;193(5):542-51. doi: 10.1164/rccm.201505-1040OC
  11. Pastorino U, Rossi M, Rosato V, Marchianò A, Sverzellati N, Morosi C, Fabbri A, Galeone C, Negri E, Sozzi G, Pelosi G, La Vecchia C. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev. 2012 May;21(3):308-15. doi: 10.1097/CEJ.0b013e328351e1b6
  12. Paci E, Puliti D, Lopes Pegna A, Carrozzi L, Picozzi G, Falaschi F, Pistelli F, Aquilini F, Ocello C, Zappa M, Carozzi FM, Mascalchi M. Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial. Thorax. 2017 Sep;72(9):825-31. doi: 10.1136/thoraxjnl-2016-209825
  13. Infante M, Lutman FR, Cavuto S, Brambilla G, Chiesa G, Passera E, Angeli E, Chiarenza M, Aranzulla G, Cariboni U, Alloisio M, Incarbone M, Testori A, Destro A, Cappuzzo F, Roncalli M, Santoro A, Ravasi G. Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial. Lung Cancer. 2008 Mar;59(3):355-63. doi: 10.1016/j.lungcan.2007.08.040
  14. Becker N, Motsch E, Gross ML, Eigentopf A, Heussel CP, Dienemann H, SchnabelPA, Eichinger M, Optazaite DE, Puderbach M, WielpÜtz M, Kauczor HU, Tremper J, Delorme S. Randomized study on early detection of lung cancer with msct in germany: results of the first 3 years of follow-up after randomization. J Thorac Oncol. 2015 Jun;10(6):890-96. doi: 10.1097/JTO.0000000000000530
  15. Lee YJ, Choi SM, Lee J, Lee CH, Lee SM, Yoo CG, Kim YW, Han SK, Park YS. Utility of the National Lung Screening Trial Criteria for Estimation of Lung Cancer in the Korean Population. Cancer Res Treat. 2018 Jul;50(3):950-55. doi: 10.4143/crt.2017.357
  16. Jaklitsch MT, Jacobson FL, Austin JH, Field JK, Jett JR, Keshavjee S, MacMahon H, Mulshine JL, Munden RF, Salgia R, Strauss GM, Swanson SJ, Travis WD, Sugarbaker DJ. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg. 2012 Jul;144(1):33-38. doi: 10.1016/j.jtcvs.2012.05.060
  17. Pastorino U, Silva M, Sestini S, Sabia F, Boeri M, Cantarutti A, Sverzellati N, Sozzi G, Corrao G, Marchianò A. Prolonged Lung Cancer Screening Reduced 10-year Mortality in the MILD Trial. Ann Oncol. 2019 Apr 1. pii: mdz117: 9-10. doi: 10.1093/annonc/mdz117
  18. Janssen-Heijnen ML, Coebergh JW. Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe. Lung Cancer. 2001 Feb-Mar;31(2-3):123-37. doi: 10.1016/S0169-5002(00)00197-5
  19. Oudkerk M, Devaraj A, Vliegenthart R, Henzler T, Prosch H, Heussel CP, Bastarrika G, Sverzellati N, Mascalchi M, Delorme S, Baldwin DR, Callister ME, Becker N, Heuvelmans MA, Rzyman W, Infante MV, Pastorino U, Pedersen JH, Paci E, Duffy SW, de Koning H, Field JK. European position statement on lung cancer screening. Lancet Oncol. 2017 Dec;18(12):e754-e66. doi: 10.1016/S1470-2045(17)30861-6
  20. Hansell DM, Bankier AA, MacMahon H, McLoud TC, MÜller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology. 2008 Mar;246(3):697-22. doi: 10.1148/radiol.2462070712
  21. Truong MT, Ko JP, Rossi SE, Rossi I, Viswanathan C, Bruzzi JF, Marom EM, Erasmus JJ. Update in the evaluation of the solitary pulmonary nodule. Radiographics. 2014 Oct;34(6):1658-79. doi: 10.1148/rg.346130092
  22. Godoy MCB, Odisio EGLC, Truong MT, de Groot PM, Shroff GS, Erasmus JJ. Pulmonary nodule management in lung cancer screening: a pictorial review of lung-RADS version 1.0. Radiol Clin North Am. 2018 May;56(3):353-63. doi: 10.1016/j.rcl.2018.01.003
  23. McKee BJ, Regis SM, McKee AB, Flacke S, Wald C. Performance of ACR Lung-RADS in a Clinical CT Lung Screening Program. J Am Coll Radiol. 2015 Mar;12(3):273-76. doi: 10.1016/j.jacr.2014.08.004
  24. Callister ME, Baldwin DR, Akram AR, Barnard S, Cane P, Draffan J, Franks K, Gleeson F, Graham R, Malhotra P, Prokop M, Rodger K, Subesinghe M, Waller D, Woolhouse I. British Thoracic Society guidelines for the investigation and management of pulmonary nodules. Thorax. 2015 Aug;70 Suppl 2:ii1-ii54. doi: 10.1136/thoraxjnl-2015-207168
  25. BTS guideline for pulmonary nodules. Guideline of the British Thoracic Society Onno Mets and Robin Smithuis the Academical Medical Centre, Amsterdam and the Alrijne Hospital, Leiderdorp, the Netherlands http://www.radiologyassistant.nl/en/p59d9bb5a1bbd7/bts-guideline-for-pulmonary-nodules.html
  26. Herder GJ, van Tinteren H, Golding RP, Kostense PJ, Comans EF, Smit EF, Hoekstra OS. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography. Chest. 2005 Oct;128(4):2490-96. doi: 10.1378/chest.128.4.2490
  27. Groheux D, Quere G, Blanc E, Lemarignier C, Vercellino L, de Margerie-Mellon C, Merlet P, Querellou S. FDG PET-CT for solitary pulmonary nodule and lung cancer: literature review. Diagn Interv Imaging. 2016 Oct;97(10):1003-17. doi: 10.1016/j.diii.2016.06.020
  28. Gombolevsky VA, Barchuk AA, Laipan ASh, Vetsheva NN, Vladzymyrskyy AV, Morosov SP. Lung ñancer screening with low-dose computed tomography: Management and efficiency. Radiologiia - Praktika. 2018;1(67):28-36. https://elibrary.ru/item.asp?id=32383822 (in Russ.)
  29. de Margerie-Mellon C, de Bazelaire C, de Kerviler E. Image-guided biopsy in primary lung cancer: Why, when and how. Diagn Interv Imaging. 2016 Oct;97(10):965-72. doi: 10.1016/j.diii.2016.06.016
  30. Rednic N, Orăşan O. Subpleural lung tumors ultrasonography. Med Ultrason. 2010 Mar; 12(1):81-87. Available from: https://pdfs.semanticscholar.org/dc7d/58e521d7fbf74e7a6c4fde908d04bd797460.pdf
  31. Anzidei M, Porfiri A, Andrani F, Di Martino M, Saba L, Catalano C, Bezzi M. Imaging-guided chest biopsies: techniques and clinical results. Insights Imaging. 2017 Aug;8(4):419-28. doi: 10.1007/s13244-017-0561-6
Information about the authors:
Gombolevsky Victor A., PhD, Head of the Department of Radiology Quality Development of Research and Practical Clinical Center of Diagnostics and Telemedicine Technologies, Moscow, Russian Federation.
https://orcid.org/0000-0003-1816-1315
Nikolaev Alexander E., Junior Researcher of the Department of Radiology Quality Development of Research and Practical Clinical Center of Diagnostics and Telemedicine Technologies, Moscow, Russian Federation.
https://orcid.org/0000-0001-5151-4579
Shapiev Arsen N., Analyst of the Department of Scientific Activities Coordination of Research and Practical Clinical Center of Diagnostics and Telemedicine Technologies, Moscow, Russian Federation.
https://orcid.org/0000-0002-1890-6711
Kosolapov Anatoly O., Radiologist of European Medical Center, Moscow, Russian Federation.
https://orcid.org/0000-0002-6257-892X
Gelezhe Pavel B., Radiologist of European Medical Center, Researcher of Research and Practical Clinical Center of Diagnostics and Telemedicine Technologies, Moscow, Russian Federation.
https://orcid.org/0000-0003-1072-2202
Barchuk Anton A., PhD, Researcher of N.N. Petrov National Medical Research Center of Oncology, Saint-Petersburg, Moscow, Russian Federation.
https://orcid.org/0000-0002-4629-3326
Dreval Petr A., PhD, Surgeon of Moscow City Oncological Hospital ¹ 62, Moscow, Russian Federation.
https://orcid.org/0000-0003-3641-868X
Esakov Yury S., PhD, Surgeon of A.V. Vishnevsky Institute of Surgery, Moscow, Russian Federation.
https://orcid.org/0000-0002-5933-924X
Morozov Sergey P., MD, Director of Research and Practical Clinical Center of Diagnostics and Telemedicine Technologies, Moscow, Russian Federation.
https://orcid.org/0000-0001-6545-6170
Contacts | ©Vitebsk State Medical University, 2007-2023